This inventor holds 28 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Wyeth, Aventis Pharmaceuticals Inc.. Active years: 2002-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bridgewater, NJ (US) (2002 - 2006)
- Royersford, PA (US) (2006 - 2010)
Company Filing History:
Years Active: 2002-2010
Areas of Expertise:
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'm delighted to provide you with an article about the accomplished inventor Ronald Charles Bernotas from Royersford, PA, in the United States.
Title: Ronald Charles Bernotas: A Pioneering Inventor from Royersford, PA
Introduction:
Ronald Charles Bernotas, a prolific inventor hailing from Royersford, PA, has made significant contributions to the field of pharmaceuticals with a total of 28 patents to his name. His innovative work has not only advanced the industry but has also brought about transformative changes in healthcare.
Latest Patents:
Among his latest patents, Ronald Charles Bernotas has developed groundbreaking compounds such as Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands. This invention offers a promising solution for the treatment of central nervous system disorders linked to the 5-HT6 receptor. Additionally, his work on Oxazolidine derivatives as PR modulators showcases his dedication to addressing hormone-related conditions effectively.
Career Highlights:
Throughout his career, Ronald Charles Bernotas has made invaluable contributions to renowned pharmaceutical companies like Wyeth and Aventis Pharmaceuticals Inc. His expertise and innovative mindset have played a pivotal role in driving advancements in the pharmaceutical sector, demonstrating his commitment to improving healthcare outcomes.
Collaborations:
Collaborating with esteemed professionals in the field, Ronald Charles Bernotas has worked alongside individuals such as Steven Edward Lenicek and Derek Cecil Cole. These collaborations have not only enriched his work but have also fostered a culture of knowledge sharing and innovation within the industry.
Conclusion:
In conclusion, Ronald Charles Bernotas stands out as a visionary inventor whose work has left an indelible mark on the pharmaceutical landscape. Through his remarkable inventions and collaborations, he continues to shape the future of healthcare, emphasizing the importance of innovation and ingenuity in addressing critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile